Anna Hockaday
University of Leeds(GB)Leeds Trinity University(GB)Cancer Research UK Clinical Trials Unit(GB)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment, Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology
Most-Cited Works
- → Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial(2018)337 cited
- → The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial(2016)148 cited
- → Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease(2023)144 cited
- → A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study(2019)106 cited
- → Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial(2023)96 cited
- → Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials